Structural Insight for Roles of DR5 Death Domain Mutations on Oligomerization of DR5 Death Domain-FADD Complex in the Death-Inducing Signaling Complex Formation: A Computational Study
Overview
Authors
Affiliations
Death receptor 5 (DR5)-induced apoptosis that prioritizes the death of tumor cells has been proposed as one of the promising cancer therapies. In this process, oligomerized DR5 death domain (DD) binding to Fas-associated death domain (FADD) leads to FADD activating caspase-8, which marks the formation of the death-inducing signaling complex (DISC) that initiates apoptosis. DR5 DD mutations found in cancer cells have been suggested to play an important pathological role, the mechanism through which those mutants prevent the DR5-activated DISC formation is not clear yet. This study sought to provide structural and molecular insight for the roles of four selected DR5 DD mutations (E355K, E367K, K415N, and L363F) in the oligomerization of DR5 DD-FADD complex during the DISC formation. Results from the molecular dynamics simulations show that the simulated mutants induce conformational, dynamical motions and interactions changes in the DR5 DD-FADD tetramer complex, including changes in a protein's backbone flexibility, less exposure of FADD DED's caspase-8 binding site, reduced H-bonding and hydrophobic contacts at the DR5 DD-FADD DD binding, altered distribution of the electrostatic potentials and correlated motions of residues, and reduced binding affinity of DR5 DD binding to FADD. This study provides structural and molecular insight for the influence of DR5 DD mutations on oligomerization of DR5 DD-FADD complex, which is expected to foster understanding of the DR5 DD mutants' resistance mechanism against DR5-activated DISC formation.
Qiu C, Zhang Z, Wine R, Campbell Z, Zhang J, Hall T Nat Commun. 2023; 14(1):7323.
PMID: 37953271 PMC: 10641069. DOI: 10.1038/s41467-023-43098-1.
Zaharias S, Fargason T, Greer R, Song Y, Zhang J Protein Sci. 2023; 32(5):e4643.
PMID: 37060324 PMC: 10127258. DOI: 10.1002/pro.4643.
Vitamin D3 and its hydroxyderivatives as promising drugs against COVID-19: a computational study.
Song Y, Qayyum S, Greer R, Slominski R, Raman C, Slominski A J Biomol Struct Dyn. 2021; 40(22):11594-11610.
PMID: 34415218 PMC: 8858339. DOI: 10.1080/07391102.2021.1964601.
Vitamin D and lumisterol derivatives can act on liver X receptors (LXRs).
Slominski A, Kim T, Qayyum S, Song Y, Janjetovic Z, Oak A Sci Rep. 2021; 11(1):8002.
PMID: 33850196 PMC: 8044163. DOI: 10.1038/s41598-021-87061-w.
Lestaurtinib potentiates TRAIL-induced apoptosis in glioma via CHOP-dependent DR5 induction.
Cao Y, Kong S, Xin Y, Meng Y, Shang S, Qi Y J Cell Mol Med. 2020; 24(14):7829-7840.
PMID: 32441887 PMC: 7348155. DOI: 10.1111/jcmm.15415.